Surgery for Graves' disease: a 25-year perspective.

[1]  B. Lang,et al.  Changing trend in surgical indication and management for Graves' disease. , 2012, American journal of surgery.

[2]  Victor M Montori,et al.  Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. , 2011, Thyroid : official journal of the American Thyroid Association.

[3]  W. S. Beattie,et al.  Chronic &bgr; Blockade Is Associated with a Better Outcome after Elective Noncardiac Surgery than Acute &bgr; Blockade: A Single-center Propensity-matched Cohort Study , 2011, Anesthesiology.

[4]  D. Larsimont,et al.  Near total thyroidectomy is an optimal treatment for graves’ disease , 2010, European Archives of Oto-Rhino-Laryngology.

[5]  C. McHenry,et al.  Total Thyroidectomy Is Superior to Subtotal Thyroidectomy for Management of Graves’ Disease in the United States , 2010, World Journal of Surgery.

[6]  C. White,et al.  Benefits and risks associated with beta-blocker prophylaxis in noncardiac surgery. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[7]  L. Hegedüs.  Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities. , 2009, Endocrinology and metabolism clinics of North America.

[8]  A. Avenell,et al.  Radioiodine therapy (RAI) for Graves’ disease (GD) and the effect on ophthalmopathy: a systematic review * , 2008, Clinical endocrinology.

[9]  Denis Xavier,et al.  Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.

[10]  G. Åkerström,et al.  Surgical Treatment of Graves’ Disease: Evidence-Based Approach , 2008, World Journal of Surgery.

[11]  L. Delbridge,et al.  Surgery versus radioiodine therapy as definitive management for graves' disease: the role of patient preference. , 2007, Thyroid : official journal of the American Thyroid Association.

[12]  E. Jaurrieta,et al.  Subtotal Thyroidectomy: A Reliable Method to Achieve Euthyroidism in Graves’ Disease. Prognostic Factors , 2006, World Journal of Surgery.

[13]  C. Solórzano,et al.  Thyroidectomy remains an effective treatment option for Graves' disease. , 2006, American journal of surgery.

[14]  Jeroen J. Bax,et al.  A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery , 2006, Coronary artery disease.

[15]  B. Barraclough,et al.  Total thyroidectomy is now the preferred option for the surgical management of Graves’ disease , 2002, ANZ journal of surgery.

[16]  M. Fried,et al.  Assessment of the morbidity and complications of total thyroidectomy. , 2002, Archives of otolaryngology--head & neck surgery.

[17]  L. Goldman,et al.  beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. , 2002, JAMA.

[18]  H. Röher,et al.  Surgery for Graves' Disease: Total versus Subtotal Thyroidectomy—Results of a Prospective Randomized Trial , 2000, World Journal of Surgery.

[19]  C. Miller,et al.  The efficacy of thyroidectomy for Graves' disease: A meta-analysis. , 2000, The Journal of surgical research.

[20]  J. Franklyn,et al.  Mortality after the treatment of hyperthyroidism with radioactive iodine. , 1998, The New England journal of medicine.

[21]  A. Pinchera,et al.  Surgical treatment of Graves' disease: subtotal or total thyroidectomy? , 1996, Surgery.

[22]  H. S. Dökmetaş,et al.  Could total thyroidectomy become the standard treatment for Graves’ disease? , 2008, Surgery Today.

[23]  S. Nagataki,et al.  Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. , 1991, Thyroid : official journal of the American Thyroid Association.